Recommendations for the Usage of Ketamine and Esketamine

氯胺酮 透明度(行为) 心理健康 目录 萧条(经济学) 心情 心理学 医学 精神科 政治学 计算机科学 万维网 法学 宏观经济学 经济
作者
Victor I. Reus
出处
期刊:American Journal of Psychiatry [American Psychiatric Association]
卷期号:178 (12): 1129-1129 被引量:2
标识
DOI:10.1176/appi.ajp.2021.21060555
摘要

Back to table of contents Previous article Next article Letters to the EditorFull AccessRecommendations for the Usage of Ketamine and EsketamineVictor I. Reus, M.D.Victor I. ReusSearch for more papers by this author, M.D.Published Online:2 Dec 2021https://doi.org/10.1176/appi.ajp.2021.21060555AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail TO THE EDITOR: The article by McIntyre et al. (1) aims to synthesize the literature on ketamine and esketamine with respect to efficacy, safety, and tolerability, and to provide guidance for implementation but provides no description of the methodology for the work involved. Given that the extensive disclosure statements reveal that a number of the authors have significant financial interests in the usage of these compounds, several questions arise: How was this “international group of mood disorder experts” selected? How was the work funded? Who wrote the paper and was a professional writing consultant involved? Is there any communication between the editorial and advertising staff regarding planned publication of a given article and simultaneous advertisements by firms marketing the agents under review?Greater transparency regarding these recurrent issues would be a desirable goal.Weill Institute for Neurosciences, University of California San Francisco Send correspondence to Dr. Reus ([email protected]).Reference1 McIntyre RS, Rosenblat JD, Nemeroff CB, et al.: Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 2021; 178:383–399Link, Google Scholar FiguresReferencesCited byDetailsCited byTreatment-resistant depression reconsideredSSM - Mental Health, Vol. 2New Insights Into Major Depression and the Treatment of Bipolar DepressionNed H. Kalin, M.D.2 December 2021 | American Journal of Psychiatry, Vol. 178, No. 12 Volume 178Issue 12 December 2021Pages 1129-1129 Metrics PDF download History Published online 2 December 2021 Published in print 1 December 2021

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郝丰富完成签到,获得积分10
1秒前
zzuzll完成签到,获得积分10
1秒前
132发布了新的文献求助10
2秒前
斯文的人达完成签到 ,获得积分10
2秒前
hhh123完成签到,获得积分10
2秒前
阿郎完成签到,获得积分10
3秒前
金岁岁完成签到,获得积分10
3秒前
刘大壮完成签到 ,获得积分10
3秒前
w1x2123完成签到,获得积分0
4秒前
4秒前
4秒前
烟花应助科研通管家采纳,获得10
4秒前
5秒前
田様应助科研通管家采纳,获得10
5秒前
5秒前
跳跃的凡柔完成签到,获得积分10
5秒前
好人完成签到,获得积分10
5秒前
宋瓜完成签到,获得积分10
6秒前
mark完成签到,获得积分10
6秒前
水滴完成签到,获得积分10
7秒前
专注的海燕完成签到,获得积分10
7秒前
gogogo完成签到,获得积分10
8秒前
tanx完成签到,获得积分10
8秒前
今天要早睡完成签到,获得积分10
8秒前
阿白完成签到,获得积分10
9秒前
而荷完成签到 ,获得积分10
9秒前
练得身形似鹤形完成签到 ,获得积分10
9秒前
TGU的小马同学完成签到 ,获得积分10
10秒前
随机发发布了新的文献求助10
10秒前
清爽念柏完成签到 ,获得积分10
10秒前
fairyinn完成签到,获得积分10
11秒前
小杜完成签到,获得积分10
11秒前
木木杨完成签到,获得积分10
12秒前
糖炒小白云完成签到,获得积分10
13秒前
Urusaiina完成签到,获得积分10
14秒前
慕青应助Arthur采纳,获得10
14秒前
淡定无施完成签到,获得积分10
15秒前
15秒前
月亮不会奔你而来完成签到,获得积分10
16秒前
郑琦敏钰完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Research Methods for Applied Linguistics 500
Picture Books with Same-sex Parented Families Unintentional Censorship 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6414035
求助须知:如何正确求助?哪些是违规求助? 8232736
关于积分的说明 17477024
捐赠科研通 5466761
什么是DOI,文献DOI怎么找? 2888516
邀请新用户注册赠送积分活动 1865364
关于科研通互助平台的介绍 1703234